(Reuters) – Ocugen Inc on Thursday said it would file for full U.S. approval of its COVID-19 vaccine candidate, COVAXIN, without pursuing an emergency use authorization.
(Reporting by Amruta Khandekar; Editing by Vinay Dwivedi)
Ocugen to file for full U.S. approval of COVID-19 vaccine
Peoria, IL, USA
63 °F Rain, Mist
